Juliet Gallagher

News
Evaluating Cost-Effectiveness of First-Line Cemiplimab Therapy in Advanced NSCLC
03/05/2025
A recent cost-effectiveness analysis published in Journal of Managed Care & Specialty Pharmacy comparing cemiplimab plus chemotherapy (CCT) with pembrolizumab plus chemotherapy (PCT) as first-line treatment for advanced non-small cell lung...
A recent cost-effectiveness analysis published in Journal of Managed Care & Specialty Pharmacy comparing cemiplimab plus chemotherapy (CCT) with pembrolizumab plus chemotherapy (PCT) as first-line treatment for advanced non-small cell lung...
A recent cost-effectiveness...
03/05/2025
Journal of Clinical Pathways
News
CAR T-Cell Therapy Cuts Costs and Improves Treatment-Free Intervals
03/04/2025
A real-world study comparing treatment patterns, health care resource utilization, and costs in patients with relapsed/refractory mantle cell lymphoma (R/R MCL) found that chimeric antigen receptor T-cell (CAR T) therapy was associated with...
A real-world study comparing treatment patterns, health care resource utilization, and costs in patients with relapsed/refractory mantle cell lymphoma (R/R MCL) found that chimeric antigen receptor T-cell (CAR T) therapy was associated with...
A real-world study comparing...
03/04/2025
Journal of Clinical Pathways
News
Timolol Maleate Ophthalmic Solution Recall Due to Defective Container
02/19/2025
FDC Limited, in coordination with the US Food and Drug Administration (FDA), has issued a voluntary recall of Timolol Maleate Ophthalmic Solution USP, 0.5% (5mL bottles, Rx only). The recall affects lot #083J033 (expiration date 09/2025) and...
FDC Limited, in coordination with the US Food and Drug Administration (FDA), has issued a voluntary recall of Timolol Maleate Ophthalmic Solution USP, 0.5% (5mL bottles, Rx only). The recall affects lot #083J033 (expiration date 09/2025) and...
FDC Limited, in coordination...
02/19/2025
Pharmacy Learning Network
News
FDA Recalls Carvedilol Tablets Due to Impurity Concerns
02/19/2025
Glenmark Pharmaceuticals and RemedyRepack Inc have issued a voluntary nationwide recall of multiple lots of carvedilol tablets due to the presence of N-Nitroso Carvedilol Impurity-1 (NNCI-I), which exceeds the US Food and Drug...
Glenmark Pharmaceuticals and RemedyRepack Inc have issued a voluntary nationwide recall of multiple lots of carvedilol tablets due to the presence of N-Nitroso Carvedilol Impurity-1 (NNCI-I), which exceeds the US Food and Drug...
Glenmark Pharmaceuticals and...
02/19/2025
Pharmacy Learning Network
News
Voluntary Recall Issued for HydrALAZINE Hydrochloride Tablets Over Quality Defects
02/19/2025
Strides Pharma Science Ltd has voluntarily recalled specific lots of HydrALAZINE Hydrochloride 25 mg tablets, distributed by McKesson Corporation under the name SKY Packaging, due to failed impurities and degradation specifications.
Strides Pharma Science Ltd has voluntarily recalled specific lots of HydrALAZINE Hydrochloride 25 mg tablets, distributed by McKesson Corporation under the name SKY Packaging, due to failed impurities and degradation specifications.
Strides Pharma Science Ltd has...
02/19/2025
Pharmacy Learning Network
News
Feasibility and Benefits of eScreening for Veterans in Community Mental Health Care
02/12/2025
A recent study published in BMC Health Services Research highlights the potential of electronic screening (eScreening) to improve the quality and coordination of mental health care for Veterans receiving treatment through the Veterans Affairs...
A recent study published in BMC Health Services Research highlights the potential of electronic screening (eScreening) to improve the quality and coordination of mental health care for Veterans receiving treatment through the Veterans Affairs...
A recent study published in BMC...
02/12/2025
Veterans Health Today
News
Study Finds At-Risk Medicare Advantage Plans Lead in Quality and Efficiency
02/11/2025
A recent study published in JAMA Network Open provides evidence that at-risk Medicare Advantage (MA) payment arrangements lead to superior quality and efficiency in health care delivery compared with fee-for-service (FFS) MA models.
A recent study published in JAMA Network Open provides evidence that at-risk Medicare Advantage (MA) payment arrangements lead to superior quality and efficiency in health care delivery compared with fee-for-service (FFS) MA models.
A recent study published in JAMA...
02/11/2025
First Report Managed Care
News
Optimizing Large Language Models for Scalable Clinical Operations
02/07/2025
A recent study published in NPJ Digital Medicine explores how large language models (LLMs) can optimize clinical workflows, shedding new light on the economic and computational challenges associated with scaling these technologies in health...
A recent study published in NPJ Digital Medicine explores how large language models (LLMs) can optimize clinical workflows, shedding new light on the economic and computational challenges associated with scaling these technologies in health...
A recent study published in NPJ...
02/07/2025
Integrated Healthcare Executive
News
90% ROI on Mental Health Benefits
02/07/2025
A recent study published in JAMA Network Open highlights the financial benefits of employer-sponsored behavioral health programs, demonstrating that these programs can result in significant net medical costs savings.
A recent study published in JAMA Network Open highlights the financial benefits of employer-sponsored behavioral health programs, demonstrating that these programs can result in significant net medical costs savings.
A recent study published in JAMA...
02/07/2025
First Report Managed Care
News
Cigna Introduces Performance-Based Reform to Improve Transparency and Access to Care
02/05/2025
Cigna has announced a performance-based initiative that ties executive compensation to customer satisfaction metrics, invests $150 million to improve care delivery and digital tools, and enhances transparency with an annual report on prior...
Cigna has announced a performance-based initiative that ties executive compensation to customer satisfaction metrics, invests $150 million to improve care delivery and digital tools, and enhances transparency with an annual report on prior...
Cigna has announced a...
02/05/2025
Integrated Healthcare Executive

Upcoming Events

Psych Congress Regionals
April 3 ⁠–⁠ April 4
Advances in Inflammatory Bowel Disease Regionals
April 5 ⁠–⁠ April 6
Rx summit logo
April 21 ⁠–⁠ April 24
April 29 ⁠–⁠ April 30
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
Psych Congress Regionals
May 1 ⁠–⁠ May 2
May 7 ⁠–⁠ May 9
NEI Congress
May 8 ⁠–⁠ May 10
Dermatology Week
May 14 ⁠–⁠ May 16
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use